Daré Bioscience (DARE) - Total Stockholders' Equity

Public company logo of Daré Bioscience (DARE)

Dare Bioscience, Inc. (DARE) operates within the non-cyclical biopharmaceutical sector, where success is driven by scientific breakthroughs rather than market conditions. This chart of share prices illustrates the asset's dynamics, with the current value standing at -0.00. Dare Bioscience, Inc. (DARE) is implementing advanced drug delivery methods for women's health, focusing on improving quality of life and solving complex medical challenges.

DARE Daré Bioscience, Inc. Book Capitalization (07/04/2022 - 10/27/2026)

Metric breakdowns and analytics for Daré Bioscience (DARE)

- price and consensus price forecast:
Price Performance Chart Daré Bioscience, Inc.|DARE - Analyst Consensus Forecast
- market capitalization data:
Market Value Dare Bioscience, Inc.|DARE - Total Company Value
- book capitalization data:
Share Book Value Daré Bioscience|DARE - Book Capitalization|Market Value to Book Value darebioscience.com|DARE - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Dare Bioscience|DARE - Company Debts|Debt to Book Value Dare Bioscience, Inc.
Fundamental valuation:DARE - Daré Bioscience, Inc.
Flagship merchandise of Dare Bioscience

The integration of ESG standards into the development of women's health products at Dare Bioscience, Inc. (DARE) is directly reflected in the tangible assets captured by the book capitalization. An analysis of capital volume via balance sheet reporting allows for an assessment of the difference between all company assets and liabilities, determining the real value of equity as the foundation of business resilience in the face of market volatility.

Competitor analysis for Dare Bioscience, Inc.

OGN - Accounting Value of Company|Book Capitalization TXMD|PTN (palatin.com) - Total Stockholders' Equity